Association between Thioridazine Use and Cancer Risk in Adult Patients with Schizophrenia-A Population-Based Study |
Chang, Cheng-Chen
(Department of Psychiatry, Changhua Christian Hospital)
Hsieh, Ming-Hong (School of Medicine, Chung Shan Medical University) Wang, Jong-Yi (Department of Health Services Administration, China Medical University) Chiu, Nan-Ying (Department of Psychiatry, Changhua Christian Hospital) Wang, Yu-Hsun (Department of Medical Research, Chung Shan Medical University Hospital) Chiou, Jeng-Yuan (Department of Health Policy and Management, Chung Shan Medical University) Huang, Hsiang-Hsiung (Department of Psychiatry, Tungs' Taichung MetroHarbor Hospital) Ju, Po-Chung (School of Medicine, Chung Shan Medical University) |
1 | Shen J, Ma B, Zhang X, Sun X, Han J, Wang Y, et al. Thioridazine has potent antitumor effects on lung cancer stem-like cells. Oncol Lett 2017;13:1563-1568. DOI |
2 | Zhang C, Gong P, Liu P, Zhou N, Zhou Y, Wang Y. Thioridazine elicits potent antitumor effects in colorectal cancer stem cells. Oncol Rep 2017;37:1168-1174. DOI |
3 | Spengler G, Molnar J, Viveiros M, Amaral L. Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein. Anticancer Res 2011;31:4201-4205. |
4 | Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nineyear follow-up study. Schizophr Res 2011;129:97-103. DOI |
5 | Yde CW, Clausen MP, Bennetzen MV, Lykkesfeldt AE, Mouritsen OG, Guerra B. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Anticancer Drugs 2009;20:723-735. DOI |
6 | Rybakowski JK, Skibinska M, Kapelski P, Kaczmarek L, Hauser J. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res 2009;109:90-93. DOI |
7 | Stocks T, Van Hemelrijck M, Manjer J, Bjorge T, Ulmer H, Hallmans G, et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension 2012;59:802-810. DOI |
8 | Radisauskas R, Kuzmickiene I, Milinaviciene E, Everatt R. Hypertension, serum lipids and cancer risk: A review of epidemiological evidence. Medicina (Kaunas) 2016;52:89-98. DOI |
9 | Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, et al. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control 2010;21:1615-1624. DOI |
10 | Seo SU, Cho HK, Min KJ, Woo SM, Kim S, Park JW, et al. Thioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression. Cell Death Dis 2017;8:e2599. DOI |
11 | Jin X, Zou B, Luo L, Zhong C, Zhang P, Cheng H, et al. Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy. Int J Nanomedicine 2016;11:4545-4552. DOI |
12 | Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, et al. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 2006;15:107-112. |
13 | Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013;75:685-705. DOI |
14 | Nagel D, Spranger S, Vincendeau M, Grau M, Raffegerst S, Kloo B, et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 2012;22:825-837. DOI |
15 | Byun HJ, Lee JH, Kim BR, Kang S, Dong SM, Park MS, et al. Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway. Microvasc Res 2012;84:227-234. DOI |
16 | Park MS, Dong SM, Kim BR, Seo SH, Kang S, Lee EJ, et al. Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts. Oncotarget 2014;5:4929-4934. |
17 | Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, et al. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis 2012;17:989-997. DOI |
18 | Mu J, Xu H, Yang Y, Huang W, Xiao J, Li M, et al. Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer. Oncol Rep 2014;31:2107-2114. DOI |
19 | Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF 3rd. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Cancer Res 1990;50:5399-5405. |
20 | Zhelev Z, Ohba H, Bakalova R, Hadjimitova V, Ishikawa M, Shinohara Y, et al. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Cancer Chemother Pharmacol 2004;53:267-275. DOI |
21 | Rho SB, Kim BR, Kang S. A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol 2011;120:121-127. DOI |
22 | Spengler G, Csonka A, Molnar J, Amaral L. The aticancer activity of the old neuroleptic phenothiazine-type drug thioridazine. Anticancer Res 2016;36:5701-5706. DOI |
23 | Yue H, Huang D, Qin L, Zheng Z, Hua L, Wang G, et al. Targeting lung cancer stem cells with antipsychological drug thioridazine. Biomed Res Int 2016;2016:6709828. |
24 | Meng Q, Sun X, Wang J, Wang Y, Wang L. The important application of thioridazine in the endometrial cancer. Am J Transl Res 2016;8:2767-2775. |